These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 6820483

  • 21. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 22. The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat.
    Rassnick S, Stinus L, Koob GF.
    Brain Res; 1993 Sep 24; 623(1):16-24. PubMed ID: 8221085
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. 6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats.
    Asher IM, Aghajanian GK.
    Brain Res; 1974 Dec 20; 82(1):1-12. PubMed ID: 4373138
    [No Abstract] [Full Text] [Related]

  • 25. Ethanol drinking following 6-OHDA lesions of nucleus accumbens and tuberculum olfactorium of the rat.
    Quarfordt SD, Kalmus GW, Myers RD.
    Alcohol; 1991 Dec 20; 8(3):211-7. PubMed ID: 1906282
    [Abstract] [Full Text] [Related]

  • 26. Antagonization of the behavioral activation produced by direct stimulation of forebrain dopamine receptors caused by intraaccumbens injections of neurotensin.
    Ervin GN, Nemeroff CB.
    Neuropsychopharmacology; 1988 Sep 20; 1(3):243-50. PubMed ID: 3150806
    [Abstract] [Full Text] [Related]

  • 27. Oxytocin-induced yawning: sites of action in the brain and interaction with mesolimbic/mesocortical and incertohypothalamic dopaminergic neurons in male rats.
    Sanna F, Argiolas A, Melis MR.
    Horm Behav; 2012 Sep 20; 62(4):505-14. PubMed ID: 22981942
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Intra-accumbens implants of embryonic dopaminergic neurons reverse the behavioral supersensitivity to opiates evoked by lesion of the mesolimbic dopaminergic pathway.
    Abrous DN, Stinus L, Le Moal M, Herman JP.
    Brain Res; 1990 Aug 13; 525(1):155-9. PubMed ID: 2245321
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.
    French ED, Pilapil C, Quirion R.
    Eur J Pharmacol; 1985 Oct 08; 116(1-2):1-9. PubMed ID: 2996909
    [Abstract] [Full Text] [Related]

  • 34. Characterization of opioid receptors in rat nucleus accumbens following mesolimbic dopaminergic lesions.
    Unterwald EM, Tempel A, Koob GF, Zukin RS.
    Brain Res; 1989 Dec 25; 505(1):111-8. PubMed ID: 2558779
    [Abstract] [Full Text] [Related]

  • 35. Effect of forebrain dopamine depletion on novelty-induced place preference behavior in rats.
    Pierce RC, Crawford CA, Nonneman AJ, Mattingly BA, Bardo MT.
    Pharmacol Biochem Behav; 1990 Jun 25; 36(2):321-5. PubMed ID: 2113297
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Lesion of dopaminergic terminals in the amygdala produces enhanced locomotor response to D-amphetamine and opposite changes in dopaminergic activity in prefrontal cortex and nucleus accumbens.
    Simon H, Taghzouti K, Gozlan H, Studler JM, Louilot A, Herve D, Glowinski J, Tassin JP, Le Moal M.
    Brain Res; 1988 May 03; 447(2):335-40. PubMed ID: 3134111
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.